John Gordon

Colleges, School and Institutes

View graph of relations

Most downloaded publications

Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: a clinical trial supporting anti-viral indications
Amy Newman, Gillian Grafton, John Curnow, Nicholas Barnes & John Gordon, Jan 2017, In: International Immunopharmacology. 42, p. 108-114

Research output: Contribution to journal › Article › peer-review

1484 downloads
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death
Michelle Holder, Anita Chamba, Stephen Young, Dagmar Scheel-Toellner, John Gordon, Nicholas Barnes, 18 Aug 2011, In: Investigational New Drugs.

Research output: Contribution to journal › Article › peer-review

205 downloads
Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation
Alexander Roberts, Tina Tang, Chiara Pallini, Graham Wallace, Alison Cooper, Aaron Scott, David Thickett, Sebastian Lugg, Thomas Pinkney, Graham Taylor, Kristian Brock, Zania Stamataki, John Curnow, John Gordon, Omar Qureshi, Nicholas Barnes & 7 others, , 17 Feb 2021, In: Scientific Reports. 11, 4030.

Research output: Contribution to journal › Article › peer-review

4 downloads

Recent publications

Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation
Alexander Roberts, Tina Tang, Chiara Pallini, Graham Wallace, Alison Cooper, Aaron Scott, David Thickett, Sebastian Lugg, Thomas Pinkney, Graham Taylor, Kristian Brock, Zania Stamataki, John Curnow, John Gordon, Omar Qureshi, Nicholas Barnes & 7 others, , 17 Feb 2021, In: Scientific Reports. 11, 4030.

Research output: Contribution to journal › Article › peer-review

Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: a clinical trial supporting anti-viral indications
Amy Newman, Gillian Grafton, John Curnow, Nicholas Barnes & John Gordon, Jan 2017, In: International Immunopharmacology. 42, p. 108-114

Research output: Contribution to journal › Article › peer-review

5-Chloroindole: a potent allosteric modulator of the 5-HT3 receptor: Allosteric modulation of the 5-HT3receptor
Amy Newman, Nikos Batis, Gillian Grafton, John Gordon, Keith Brain, Andrew Powell & Nicholas Barnes, Jul 2013, In: British Journal of Pharmacology. 169, 6, p. 1228-1238 11 p.

Research output: Contribution to journal › Article › peer-review

View all (64)